Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans.

Gao S, Unverzagt FW, Hall KS, Lane KA, Murrell JR, Hake AM, Smith-Gamble V, Hendrie HC.

Am J Geriatr Psychiatry. 2014 Jul;22(7):670-81. doi: 10.1016/j.jagp.2013.02.015. Epub 2013 Jul 3.

2.

Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.

Brodaty H, Heffernan M, Kochan NA, Draper B, Trollor JN, Reppermund S, Slavin MJ, Sachdev PS.

Alzheimers Dement. 2013 May;9(3):310-317.e1. doi: 10.1016/j.jalz.2011.11.010. Epub 2012 Oct 27.

PMID:
23110866
3.

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC.

Neurology. 2014 Jan 28;82(4):317-25. doi: 10.1212/WNL.0000000000000055. Epub 2013 Dec 18.

4.

Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study.

Low LF, Harrison F, Kochan NA, Draper B, Slavin MJ, Reppermund S, Sachdev PS, Brodaty H.

Am J Geriatr Psychiatry. 2012 Oct;20(10):866-77. doi: 10.1097/JGP.0b013e31823e31e2.

PMID:
22261551
5.

Outcomes of mild cognitive impairment by definition: a population study.

Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander Bilt J, Hughes TF, Loewenstein DA, Unverzagt FW, Petersen RC.

Arch Neurol. 2011 Jun;68(6):761-7. doi: 10.1001/archneurol.2011.101.

6.

Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.

Hobson P, Meara J.

Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11.

PMID:
25676160
7.

Validity of the montreal cognitive assessment as a screen for mild cognitive impairment and dementia in African Americans.

Goldstein FC, Ashley AV, Miller E, Alexeeva O, Zanders L, King V.

J Geriatr Psychiatry Neurol. 2014 Sep;27(3):199-203. doi: 10.1177/0891988714524630. Epub 2014 Mar 10.

PMID:
24614202
8.

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

Neurology. 2017 Feb 21;88(8):767-774. doi: 10.1212/WNL.0000000000003634. Epub 2017 Jan 20.

PMID:
28108638
9.

Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans.

Unverzagt FW, Ogunniyi A, Taler V, Gao S, Lane KA, Baiyewu O, Gureje O, Smith-Gamble V, Hake A, Hendrie HC, Hall KS.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):4-10. doi: 10.1097/WAD.0b013e3181f1c8b1.

10.

Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.

Ng TP, Feng L, Nyunt MS, Feng L, Gao Q, Lim ML, Collinson SL, Chong MS, Lim WS, Lee TS, Yap P, Yap KB.

JAMA Neurol. 2016 Apr;73(4):456-63. doi: 10.1001/jamaneurol.2015.4899.

PMID:
26926205
11.

Accelerated weight loss and incident dementia in an elderly African-American cohort.

Gao S, Nguyen JT, Hendrie HC, Unverzagt FW, Hake A, Smith-Gamble V, Hall K.

J Am Geriatr Soc. 2011 Jan;59(1):18-25. doi: 10.1111/j.1532-5415.2010.03169.x. Epub 2010 Nov 4.

12.

Frequency and course of mild cognitive impairment in a multiethnic community.

Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R.

Ann Neurol. 2008 Apr;63(4):494-506. doi: 10.1002/ana.21326.

13.

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.

PMID:
23529397
14.

Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.

Chen Y, Denny KG, Harvey D, Farias ST, Mungas D, DeCarli C, Beckett L.

Alzheimers Dement. 2017 Apr;13(4):399-405. doi: 10.1016/j.jalz.2016.07.151. Epub 2016 Aug 30.

15.

Effects of MCI subtype and reversion on progression to dementia in a community sample.

Aerts L, Heffernan M, Kochan NA, Crawford JD, Draper B, Trollor JN, Sachdev PS, Brodaty H.

Neurology. 2017 Jun 6;88(23):2225-2232. doi: 10.1212/WNL.0000000000004015. Epub 2017 May 10.

PMID:
28490651
16.

Mild cognitive impairment and dementia in primary care: the value of medical history.

Olazarán J, Torrero P, Cruz I, Aparicio E, Sanz A, Mula N, Marzana G, Cabezón D, Begué C.

Fam Pract. 2011 Aug;28(4):385-92. doi: 10.1093/fampra/cmr005. Epub 2011 Mar 14.

PMID:
21402661
17.

Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.

Di Carlo A, Baldereschi M, Lamassa M, Bovis F, Inzitari M, Solfrizzi V, Panza F, Galluzzo L, Scafato E, Inzitari D; Italian Longitudinal Study on Aging Working Group.

J Alzheimers Dis. 2016 May 7;53(2):505-15. doi: 10.3233/JAD-160087.

PMID:
27163817
18.
19.

Does mild cognitive impairment always lead to dementia? A review.

Pandya SY, Clem MA, Silva LM, Woon FL.

J Neurol Sci. 2016 Oct 15;369:57-62. doi: 10.1016/j.jns.2016.07.055. Epub 2016 Jul 26. Review.

PMID:
27653867
20.

Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study.

Lopez OL, Becker JT, Chang YF, Sweet RA, DeKosky ST, Gach MH, Carmichael OT, McDade E, Kuller LH.

Neurology. 2012 Oct 9;79(15):1599-606. doi: 10.1212/WNL.0b013e31826e25f0. Epub 2012 Sep 26.

Supplemental Content

Support Center